FDA 483 - Hill Laboratories - July 27, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Hill Laboratories, a medical device manufacturer in Frazer, PA, was cited with 11 observations during an FDA inspection from June 29 to July 27, 2022. The inspection revealed significant deficiencies across its quality system, including failures in MDR reporting, complaint handling, CAPA procedures, design control, device acceptance, equipment calibration, device master records, management reviews, and internal audits. These issues indicate a systemic breakdown in maintaining an effective quality system for medical device manufacturing.
ID · 612ae939-0a1a-4102-8d2f-4ad122ae3c59